Stereotaxis Continues Its Turnaround, Bringing Robots To Endovascular Intervention
Executive Summary
In an interview with Medtech Insight, Stereotaxis CEO David Fischel explained how the company intends to continue its recovery after a troubled near decade of decline.
You may also be interested in...
Boston Scientific TheraSphere Liver Cancer Treatment Succeeds In EPOCH Trial
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.
Pixee Medical Concludes Knee+ Study Highlighting Its Efficacy
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.
Device Week, 16 September 2021 – AAOS Conference Wrap-up; Exciting New Diagnostic Method
In this week's podcast Medtech Insight’s Marion Webb gives a summary of this year’s American Academy Of Orthopedic Surgeons annual meeting, where she discusses new products from a range of companies, and interesting meetings with executives. UK-based reporter Barnaby Pickering sheds light on Owlstone Medical’s new diagnostic method, and managing editor Reed Miller highlights a story about the troubled Stereotaxis.